Global Oncology Based Molecular Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, and Reagents), By Technology (Polymerase Chain Reaction, Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification), By Application (Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Cervical Cancer), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare
RELEASE DATE Jul 2024
REPORT ID SI4729
PAGES 211
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Product
      2. Market Attractiveness Analysis By Technology
      3. Market Attractiveness Analysis By Application
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Technological improvements in diagnostic analysis
    3. Restraints
      1.  Expensive molecular diagnostic test rates
    4. Opportunities
      1. Complementary diagnostics are becoming more and more important in the medication development process   
    5. Challenges
      1. Strict regulatory environment
  6. Global Oncology Based Molecular Diagnostics Market Analysis and Projection, By Product
    1. Segment Overview
    2. Instruments
    3. Reagents
  7. Global Oncology Based Molecular Diagnostics Market Analysis and Projection, By Technology
    1. Segment Overview
    2. Polymerase Chain Reaction
    3. Chips & Microarrays
    4. Sequencing
    5. Mass Spectroscopy
    6. Transcription Mediated Amplification
  8. Global Oncology Based Molecular Diagnostics Market Analysis and Projection, By Application
    1. Segment Overview
    2. Breast Cancer
    3. Prostate Cancer
    4. Colorectal Cancer
    5. Skin Cancer
    6. Cervical Cancer
  9. Global Oncology Based Molecular Diagnostics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Oncology Based Molecular Diagnostics Market Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Oncology Based Molecular Diagnostics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Abbott
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   BD 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Bayer AG 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Cepheid 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Agilent Technologies, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Danaher
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Biocartis Group NV
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Hologic, Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Qiagen
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  F. Hoffmann-La Roche Ltd 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Siemens Healthcare GmbH
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sysmex Europe GmbH
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  BioMérieux SA 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Veracyte Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  2. Global Instruments, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  3. Global Reagents, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  4. Global Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  5. Global Polymerase Chain Reaction, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  6. Global Chips & Microarrays, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  7. Global Sequencing, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  8. Global Mass Spectroscopy, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  9. Global Transcription Mediated Amplification, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  10. Global Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  11. Global Breast Cancer, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  12. Global Prostate Cancer, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  13. Global Colorectal Cancer, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  14. Global Skin Cancer, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  15. Global Cervical Cancer, Oncology Based Molecular Diagnostics Market, By Region, 2023-2033(USD Billion)
  16. North America Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  17. North America Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  18. North America Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  19. U.S.  Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  20. U.S.  Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  21. U.S.  Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  22. Canada Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  23. Canada Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  24. Canada Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  25. Mexico Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  26. Mexico Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  27. Mexico Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  28. Europe Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  29. Europe Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  30. Europe Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  31. Germany Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  32. Germany Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  33. Germany Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)  
  34. France Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  35. France Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  36. France Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  37. U.K.  Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  38. U.K.  Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  39. U.K.  Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)  
  40. Italy Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  41. Italy Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  42. Italy Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)  
  43. Spain Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  44. Spain Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  45. Spain Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  46. Asia Pacific Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  47. Asia Pacific Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  48. Asia Pacific Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  49. Japan Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  50. Japan Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  51. Japan Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  52. China Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  53. China Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  54. China Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  55. India Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  56. India Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  57. India Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  58. South America Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  59. South America Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  60. South America Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  61. Brazil Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  62. Brazil Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  63. Brazil Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  64. The Middle East and Africa Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD   Billion)
  65. The Middle East and Africa Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD   Billion)
  66. The Middle East and Africa Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  67. UAE Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  68. UAE Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  69. UAE Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)
  70. South Africa Oncology Based Molecular Diagnostics Market, By Product, 2023-2033(USD Billion)
  71. South Africa Oncology Based Molecular Diagnostics Market, By Technology, 2023-2033(USD Billion)
  72. South Africa Oncology Based Molecular Diagnostics Market, By Application, 2023-2033(USD Billion)

List of Figures 

  1. Global Oncology Based Molecular Diagnostics Market Segmentation
  2. Oncology Based Molecular Diagnostics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Oncology Based Molecular Diagnostics Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Oncology Based Molecular Diagnostics Market
  20. Oncology Based Molecular Diagnostics Market Segmentation, By Product
  21. Oncology Based Molecular Diagnostics Market For Instruments, By Region, 2023-2033 ($ Billion)
  22.  Oncology Based Molecular Diagnostics Market For Reagents, By Region, 2023-2033 ($ Billion)
  23. Oncology Based Molecular Diagnostics Market Segmentation, By Technology
  24.  Oncology Based Molecular Diagnostics Market For Polymerase Chain Reaction, By Region, 2023-2033 ($ Billion)
  25.  Oncology Based Molecular Diagnostics Market For Chips & Microarrays, By Region, 2023-2033 ($ Billion)
  26. Oncology Based Molecular Diagnostics Market For Sequencing, By Region, 2023-2033 ($ Billion)
  27. Oncology Based Molecular Diagnostics Market For Mass Spectroscopy, By Region, 2023-2033 ($ Billion)
  28. Oncology Based Molecular Diagnostics Market For Transcription Mediated Amplification, By Region, 2023-2033 ($ Billion)
  29. Oncology Based Molecular Diagnostics Market Segmentation, By Application
  30. Oncology Based Molecular Diagnostics Market For Breast Cancer, By Region, 2023-2033 ($ Billion)
  31. Oncology Based Molecular Diagnostics Market For Prostate Cancer, By Region, 2023-2033 ($ Billion)
  32. Oncology Based Molecular Diagnostics Market For Colorectal Cancer, By Region, 2023-2033 ($ Billion)
  33. Oncology Based Molecular Diagnostics Market For Skin Cancer, By Region, 2023-2033 ($ Billion)
  34. Oncology Based Molecular Diagnostics Market For Cervical Cancer, By Region, 2023-2033 ($ Billion)
  35. Abbott: Net Sales, 2023-2033 ($ Billion)
  36. Abbott: Revenue Share, By Segment, 2023 (%)
  37. Abbott: Revenue Share, By Region, 2023 (%)
  38. BD: Net Sales, 2023-2033 ($ Billion)
  39. BD: Revenue Share, By Segment, 2023 (%)
  40. BD: Revenue Share, By Region, 2023 (%)
  41. Bayer AG: Net Sales, 2023-2033 ($ Billion)
  42. Bayer AG: Revenue Share, By Segment, 2023 (%)
  43. Bayer AG: Revenue Share, By Region, 2023 (%)
  44. Cepheid: Net Sales, 2023-2033 ($ Billion)
  45. Cepheid: Revenue Share, By Segment, 2023 (%)
  46. Cepheid: Revenue Share, By Region, 2023 (%)
  47. Agilent Technologies, Inc.: Net Sales, 2023-2033 ($ Billion)
  48. Agilent Technologies, Inc.: Revenue Share, By Segment, 2023 (%)
  49. Agilent Technologies, Inc.: Revenue Share, By Region, 2023 (%)
  50. Danaher: Net Sales, 2023-2033 ($ Billion)
  51. Danaher: Revenue Share, By Segment, 2023 (%)
  52. Danaher: Revenue Share, By Region, 2023 (%)
  53. Biocartis Group NV: Net Sales, 2023-2033 ($ Billion)
  54. Biocartis Group NV: Revenue Share, By Segment, 2023 (%)
  55. Biocartis Group NV: Revenue Share, By Region, 2023 (%)
  56. Hologic, Inc: Net Sales, 2023-2033 ($ Billion)
  57. Hologic, Inc: Revenue Share, By Segment, 2023 (%)
  58. Hologic, Inc: Revenue Share, By Region, 2023 (%)
  59. Qiagen: Net Sales, 2023-2033 ($ Billion)
  60. Qiagen: Revenue Share, By Segment, 2023 (%)
  61. Qiagen: Revenue Share, By Region, 2023 (%)
  62. F. Hoffmann-La Roche Ltd: Net Sales, 2023-2033 ($ Billion)
  63. F. Hoffmann-La Roche Ltd: Revenue Share, By Segment, 2023 (%)
  64. F. Hoffmann-La Roche Ltd: Revenue Share, By Region, 2023 (%)
  65. Siemens Healthcare GmbH: Net Sales, 2023-2033 ($ Billion)
  66. Siemens Healthcare GmbH: Revenue Share, By Segment, 2023 (%)
  67. Siemens Healthcare GmbH: Revenue Share, By Region, 2023 (%)
  68. Sysmex Europe GmbH: Net Sales, 2023-2033 ($ Billion)
  69. Sysmex Europe GmbH: Revenue Share, By Segment, 2023 (%)
  70. Sysmex Europe GmbH: Revenue Share, By Region, 2023 (%)
  71. BioMérieux SA: Net Sales, 2023-2033 ($ Billion)
  72. BioMérieux SA: Revenue Share, By Segment, 2023 (%)
  73. BioMérieux SA: Revenue Share, By Region, 2023 (%)
  74. Veracyte Inc: Net Sales, 2023-2033 ($ Billion)
  75. Veracyte Inc: Revenue Share, By Segment, 2023 (%)
  76. Veracyte Inc: Revenue Share, By Region, 2023 (%)
  77. Others: Net Sales, 2023-2033 ($ Billion)
  78. Others: Revenue Share, By Segment, 2023 (%)
  79. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:120
Pages:211
Countries covered:17
Companies covered::20
Forecast CAGR:11.96%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies